白雲山(600332.SH):辛夷鼻炎丸、調經益母片通過澳大利亞TGA-GMP認證
格隆匯5月17日丨白雲山(600332.SH)公佈,近日,公司全資子公司中一藥業收到澳大利亞藥物管理局(TGA)頒發的GMP證書,TGA是Therapeutic Goods Administration的簡寫,全稱是澳大利亞藥物管理局。
中一藥業本次TGA-GMP認證生產線3條,為製造一部、製造二部、製造三部丸劑生產線和片劑生產線,以及製造四部中藥前處理生產線。本次認證累計投入費用約人民幣31萬元(未經審計)。
本次TGA-GMP認證涉及主要產品市場情況:
1.辛夷鼻炎丸;功能主治:祛風,清熱,解毒。用於鼻炎;根據米內網數據顯示,2021年藥品辛夷鼻炎丸在國內城市、縣級公立醫院、實體藥店的銷售額為人民幣769萬元,2021年中一藥業該產品銷售額為人民幣360萬元。
2.調經益母片;功能主治:調經活血。用於月經後錯,量少,經期腹痛;根據米內網數據顯示,2021年藥品調經益母片在國內實體藥店的銷售額為人民幣313萬元,2021年中一藥業該產品銷售額為人民幣10萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.